Publications:279
Accepting New Patients
- Treats Adults
- Accepting New Patients
Howard M Fillit, MD
Internal Medicine, Geriatrics, Palliative Care
About Me
Howard Fillit, MD is a board certified geriatrician and a neuroscientist. He is the founding Executive Director of the Institute for the Study of Aging, an Estée Lauder family foundation, and the Alzheimer’s Drug Discovery Foundation, organizations with a common mission of accelerating drug discovery for Alzheimer’s disease through venture philanthropy. Dr. Fillit has had a distinguished academic medicine career at The Rockefeller University and The Mount Sinai School of Medicine where he is currently a clinical professor of geriatrics, medicine and neuroscience. He is the author or co-author of more than 300 scientific and clinical publications, and is the senior editor of the leading international Textbook of Geriatric Medicine and Gerontology. Dr. Fillit has received several awards and honors including the Rita Hayworth Award for Lifetime Achievement from the Alzheimer’s Association. Throughout his career, he has maintained a limited private practice in consultative geriatric medicine with a focus on Alzheimer’s disease and related dementias.
Language
English
Position
CLINICAL PROFESSOR | Geriatrics and Palliative Medicine, CLINICAL PROFESSOR | Medicine, CLINICAL PROFESSOR | Neuroscience
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Education
BA, Cornell University
MD, SUNY Upstate Medical University College of Medicine
Residency, Internal Medicine
Beth Israel Medical Center-Petrie Division
Fellowship, Nephrology
Hospital for Special Surgery
Certifications
American Board of Internal Medicine
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Implementing early detection of cognitive impairment in primary care to improve care for older adults. Nicole R. Fowler, Katherine A. Partrick, James Taylor, Michael Hornbecker, Kevin Kelleher, Malaz Boustani, Jeffrey L. Cummings, Tim MacLeod, Michelle M. Mielke, Jared R. Brosch, Janice Lee, Eli Shobin, James E. Galvin, Howard Fillit, Chinedu Udeh-Momoh, Deanna R. Willis. Journal of Internal Medicine
- Local molecular and connectomic contributions of tau-related neurodegeneration. Fardin Nabizadeh, Ansgar J. Furst, Joy L. Taylor, Jerome A. Yesavage, Gail Li, Eric C. Petrie, Elaine R. Peskind, Sandra Harding, JJay Fruehling, Dino Massoglia, Olga James, Konstantinos Arfanakis, Debra Fleischman, Karl Friedl, Shannon Finley, Jacqueline Hayes, Rosemary Morrison, Melissa Davis, Jordan Grafman, Thomas Neylan, Balebail Ashok Raj, Kristin Fargher, Amanda Smith, Lisa Raudin, Gloria Chaing, Norman Relkin, Karen Elizabeth Smith, Hyungsub Shim, Laura L.Boles Ponto, Susan K. Schultz, Antero Sarrael, Raymundo Hernando, Nunzio Pomara, Dick Drost, Irina Rachinsky, Stephen Pasternak, David Bachman, Kenneth Spicer, Jacobo Mintzer, Bruce L. Miller, Howard J. Rosen, Stephen Correia, Paul Malloy, Stephen Salloway, Geoffrey Tremont, Henry Querfurth, Brian R. Ott, Franklin Watkins, Hillel Grossman, Howard Fillit. GeroScience
- Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation. Jeffrey Cummings, Michael Gold, Mark Mintun, Michael Irizarry, Andrew von Eschenbach, Suzanne Hendrix, Donald Berry, Cristina Sampaio, Kaycee Sink, Jaren Landen, Miia Kivipelto, Michael Grundman, Steven E. Arnold, Allan Green, Katherine Partrick, Laura Nisenbaum, Aaron Burstein, Howard Fillit. The journal of prevention of Alzheimer's disease
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Fillit during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Alector
- LifeWorx
- Eli Lilly and Company
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.